Frost Brown Todd has announced it is merging with Newark-based Gibbons as of Jan. 1, 2026. The combined firm, which will be named FBT Gibbons, will be home to roughly 800 lawyers across 25 offices.

Researchers have discovered a novel criterion for sorting particles in microfluidic channels, paving the way for advancements in disease diagnostics and liquid biopsies. Using the supercomputer ...

Equinor could combine its renewable energy assets with those of Orsted, according to the Norwegian major's chairman, sending shares in the stricken Danish offshore wind group rising. Norway's Equinor ...

DUBUQUE, Iowa (KCRG) - Archbishop Thomas Zinkula announced a plan to merge parishes across the Archdiocese of Dubuque, affecting thousands of Eastern Iowa Catholics who attend weekend mass. The number ...

June 10 (Reuters) - Recursion Pharmaceuticals (RXRX.O), opens new tab said on Tuesday it would lay off about 20% of its workforce as the biotech company tries to cope with an industry-wide funding ...

Evidently in the mood for some spring cleaning, Salt Lake City’s Recursion is clearing out a chunk of its pipeline as it narrows its focus on R&D in oncology and rare diseases. The move comes roughly ...

Elon Musk’s team is leading an effort to link government databases, to the alarm of privacy and security experts. By Emily Badger and Sheera Frenkel The federal government knows your mother’s maiden ...

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community. Issues are used to track todos, bugs, feature requests, and more.

Eye-focused biotechs Tenpoint Therapeutics and Visus Therapeutics are joining forces, setting their sights on filing a new drug approval application next year for a presbyopia-correcting eye drop.